omeprazole and Blindness
omeprazole has been researched along with Blindness in 7 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"During the following 2 weeks, amaurosis persisted on the left eye." | 2.48 | Blindness following severe midfacial trauma--case report and review. ( Hingst, V; Lenz, JH; Roth, J, 2012) |
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Roth, J | 1 |
Hingst, V | 1 |
Lenz, JH | 1 |
Lessell, S | 1 |
Classen, M | 1 |
Blum, AL | 1 |
Creutzfeldt, W | 1 |
Labenz, J | 1 |
Stolte, M | 2 |
Günther, K | 1 |
Reviews
1 review available for omeprazole and Blindness
Article | Year |
---|---|
Blindness following severe midfacial trauma--case report and review.
Topics: Anti-Inflammatory Agents; Anti-Ulcer Agents; Blindness; Dexamethasone; Facial Bones; Glucocorticoids | 2012 |
Other Studies
6 other studies available for omeprazole and Blindness
Article | Year |
---|---|
[Federal health office commentaries: false, misleading citations].
Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Germany; Humans; Omeprazole; | 1995 |
[Who is affected by blindness?].
Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Deafness; Drug Approval; Huma | 1995 |
[We hope that the responsible persons learn from the experience!].
Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Deafness; Drug Approval; Germ | 1995 |
[Vision and hearing disorders with omeprazole: the facts].
Topics: Blindness; Deafness; Gastrointestinal Diseases; Germany; Humans; Omeprazole; Product Surveillance, P | 1995 |
["A defective public health office monitors health"].
Topics: Blindness; Drug Approval; Germany; Humans; Infusions, Intravenous; Omeprazole; Product Surveillance, | 1995 |
["A sick public health services watches over health status": how the former Federal Public Health Office turned German medicine exemplified by "omeprazole and blindness" into an international joke].
Topics: Blindness; Deafness; Drug Approval; Germany; Humans; Omeprazole; Quality Assurance, Health Care | 1994 |